Colorectal
GCT1158-08
A Randomized, Open label, Phase 3 Trial of Petosemtamab in Combination With mFOLFOX6 or FOLFIRI versus Cetuximab in Combination With mFOLFOX6 or FOLFIRI as First-line Treatment in Participants with RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
Trial overview
Clinical Area
Medical Oncology
Disease
Gastrointestinal (GI)
Disease site
Colorectal
Study Phase
III
Trial Identifiers
Registration number: NCT07702032
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries